Department of Psychiatry, Dalhousie University, Halifax, Nova Scotia, Canada.
Eating Disorder Program, Nova Scotia Health Authority, Halifax, Nova Scotia, Canada.
Eur Eat Disord Rev. 2020 Jul;28(4):473-479. doi: 10.1002/erv.2727. Epub 2020 Feb 12.
Although self-monitoring is an important part of eating disorder treatment, non-adherence is commonly observed among patients asked to maintain paper food records. This study aims to compare the efficacy and acceptability of electronic self-monitoring via Recovery Record to self-monitoring via traditional paper records, in an intensive outpatient (IOP) eating disorder treatment for adults.
Ninety patients were recruited from an IOP eating disorder clinic and randomly assigned to the experimental or control condition. Those in the control condition received the standard treatment delivered by the IOP programme, including the use of paper records for self-monitoring. Those in the experimental condition received the same treatment but used Recovery Record for self-monitoring.
The results did not demonstrate statistically significant group differences over time on eating disorder symptomatology, and there were no statistically significant group differences on acceptability or adherence.
Our pilot efficacy data do not support superiority of the app over paper records in an IOP setting, so proceeding to a larger efficacy trial is not warranted. Future studies should aim to determine whether the app is efficacious as an adjunct to less intensive treatment or to further explore adherence and acceptability outcomes in studies with larger sample sizes.
ClinicalTrials.gov Identifier: NCT02484794.
尽管自我监测是饮食失调治疗的重要组成部分，但要求患者维持纸质食物记录时，通常会观察到不依从的情况。本研究旨在比较通过 Recovery Record 进行电子自我监测与通过传统纸质记录进行自我监测，在成人强化门诊（IOP）饮食失调治疗中的疗效和可接受性。
从 IOP 饮食失调诊所招募了 90 名患者，并将其随机分配到实验组或对照组。对照组接受 IOP 计划提供的标准治疗，包括使用纸质记录进行自我监测。实验组接受相同的治疗，但使用 Recovery Record 进行自我监测。
研究结果未显示在饮食失调症状学方面，随时间的组间差异具有统计学意义，且在可接受性或依从性方面也没有统计学意义的组间差异。
我们的初步疗效数据不支持在 IOP 环境中，应用程序优于纸质记录，因此没有必要进行更大规模的疗效试验。未来的研究应旨在确定该应用程序作为较不密集治疗的辅助手段是否有效，或在更大样本量的研究中进一步探讨依从性和可接受性结果。
ClinicalTrials.gov 标识符：NCT02484794。
